首页 | 本学科首页   官方微博 | 高级检索  
     

ERCP/EST-LC治疗胆囊结石合并胆总管结石临床疗效及并发症
引用本文:陈永艺,陈华福,錡和强,钟 伟,邹燕慧. ERCP/EST-LC治疗胆囊结石合并胆总管结石临床疗效及并发症[J]. 现代生物医学进展, 2021, 0(5): 867-870
作者姓名:陈永艺  陈华福  錡和强  钟 伟  邹燕慧
作者单位:厦门大学附属东南医院普外科 福建 漳州363000
基金项目:全军后勤科研面上项目(CWH17J030)
摘    要:目的:考察内镜下逆行胰胆管造影术/十二指肠乳头括约肌切开术加腹腔镜胆囊切除术(endoscopic retrograde pancreatic angiography/endoscopic sphincterotomy-1 aparoscopic cholecystectomy,ERCP/EST-LC)对胆囊结石合并胆...

关 键 词:ERCP/EST-LC  胆囊结石  胆总管结石  疗效  并发症
收稿时间:2020-08-06
修稿时间:2020-08-31

Clinical Efficacy and Complications of ERCP/EST-LC in the Treatment of Gallstones Combined with Choledocholithiasis
CHEN Yong-yi,CHEN Hua-fu,QI He-qiang,ZHONG Wei,ZOU Yan-hui. Clinical Efficacy and Complications of ERCP/EST-LC in the Treatment of Gallstones Combined with Choledocholithiasis[J]. Progress in Modern Biomedicine, 2021, 0(5): 867-870
Authors:CHEN Yong-yi  CHEN Hua-fu  QI He-qiang  ZHONG Wei  ZOU Yan-hui
Affiliation:(Department of General Surgery,The Affiliated Dongnan Hospital of Xiamen University,Zhangzhou,Fujian,363000,China)
Abstract:Objective:To investigate the clinical efficacy and safety of ERCP/EST-LC on gallbladder stones combined with common bile duct stones.Methods:Taking 80 patients with gallbladder stones and common bile duct stones as the research objects,they were divided into the study group and the control group by random number table method,with 40 cases in each group.The control group underwent LCBDE-LC surgery,and the study group underwent ERCP/EST-LC surgery.The clinical efficacy of patients was investigated by indicators such as surgical success rate,perioperative indicators and postoperative complications.Results:The operation success rate of the control group was 95.0%,and the operation success rate of the study group was 97.5%.There was no significant difference between the two groups(P>0.05).There was no significant difference in the operation time and intraoperative blood loss of the study group compared with the control group.(P>0.05),the recovery time of gastrointestinal function in the study group was 39.64±5.34 h,which was significantly longer than 37.19±3.17 h in the control group(P<0.05),and the hospital stay in the study group was 14.17±2.06 d,which was significantly longer than the control group 11.85±2.71 d(P<0.05).There was no significant difference in the incidence of biliary tract infection,acute pancreatitis,intestinal perforation,residual stones,and cholangitis between the two groups(P>0.05).The incidence of bile leakage in the control group was 7.50%,which was significantly higher than the 0.00%in the study group(P<0.05),and the incidence of postoperative bleeding in the study group was 10.00%,which was significantly higher than 2.50%in the control group(P<0.05).The total incidence of complications was 12.50%in the control group,and 15.00%in the study group.There was no significant difference between the two groups(P>0.05).The one-year recurrence rate of the control group was 15.00%,and the recurrence rate of the study group was 17.50%.According to statistical analysis,there was no significant difference in the recurrence rate between the two groups(P>0.05).The remaining patients had no abdominal pain,fever,jaundice.Conclusion:ERCP/EST-LC treatment of gallbladder stones combined with choledocholithiasis has definite clinical curative effect,few complications and high safety.
Keywords:ERCP/EST-LC   Gallbladder stones   Common bile duct stones   Curative effect   Complications
本文献已被 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号